Axsome Therapeutics (AXSM) had the highest return in 2019 by a US stock with a market cap of $500M+, returning 3,578.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 2019 | 3,578.29% |
Teekay Tankers (TNK) | 2019 | 2,442.92% |
EverQuote Inc Class A (EVER) | 2019 | 725.72% |
Neurogene (NGNE) | 2019 | 473.02% |
Enphase Energy (ENPH) | 2019 | 464.36% |
Pennant (PNTG) | 2019 | 437.72% |
Arrowhead Pharmaceuticals (ARWR) | 2019 | 421.63% |
Roku (ROKU) | 2019 | 349.03% |
MiMedx (MDXG) | 2019 | 345.88% |
Ardelyx (ARDX) | 2019 | 341.47% |
Centrus Energy (LEU) | 2019 | 319.51% |
Fulgent Genetics (FLGT) | 2019 | 306.94% |
Opthea (OPT) | 2019 | 289.6% |
Aspen Aerogels (ASPN) | 2019 | 264.32% |
Sea (SE) | 2019 | 261.69% |
Borr Drilling (BORR) | 2019 | 254.9% |
Sibanye Gold Ltd ADR (SBSW) | 2019 | 243.6% |
Immunitybio (IBRX) | 2019 | 238.39% |
Arvinas (ARVN) | 2019 | 224.82% |
Iovance Biotherapeutics (IOVA) | 2019 | 215.62% |
Alphatec (ATEC) | 2019 | 213.94% |
Intracellular Th (ITCI) | 2019 | 208.54% |
Snap (SNAP) | 2019 | 203.53% |
Zymeworks Inc Common Stock (ZYME) | 2019 | 203.07% |
Aurinia Pharmaceuticals (AUPH) | 2019 | 201.94% |
